SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-270355
Filing Date
2023-11-03
Accepted
2023-11-03 16:01:50
Documents
3
Group Members
ACCESS INDUSTRIES HOLDINGS LLCAI BIOTECHNOLOGY LLCLEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13G d691499dsc13g.htm SC 13G 90941
2 EX-99.1 d691499dex991.htm EX-99.1 7096
3 EX-99.2 d691499dex992.htm EX-99.2 7946
  Complete submission text file 0001193125-23-270355.txt   107708
Mailing Address 730 FIFTH AVENUE NEW YORK NY 10019
Business Address 730 FIFTH AVENUE NEW YORK NY 10019 2122476400
ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by) CIK: 0001508226 (see all company filings)

IRS No.: 133970710 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Subject) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94122 | Film No.: 231376227
SIC: 2836 Biological Products, (No Diagnostic Substances)